Immuneering Banner Image


  • Ticker IMRX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Immuneering Logo Image
  • 51-200 Employees
  • Based in Cambridge, Massachusetts
Immuneering is a biopharmaceutical company with an emerging pipeline focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying its deep knowledge of translational bioinformatics to every stage of the drug development process. Immuneering has more than a decade of experience in translational bioinformatics and generatingMore insights into drug mechanisms of action and patient treatment responses. Building on this experience, Immuneering has developed a disease-agnostic platform that enables the company to utilize human data, novel biology and chemistry, and translational planning to create and advance its wholly owned pipeline. Immuneering’s current development programs in oncology are focused on providing potential treatments for patients with solid tumors caused by mutations of oncologic signaling pathways, including the MAPK pathway.
5.0 / 5.0 (1)

Immuneering reports have an aggregate usefulness score of 5.0 based on 1 reviews.


Most Recent Responsibility Report

MOST RECENT 2022 Sustainability Report

Immuneering does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information
Our service enables potential investors to review the most recent and archived Immuneering Sustainability Report, Immuneering Corporate Social Responsibility Report, Immuneering CSR Report, Immuneering Corporate Responsibility, Immuneering CR Report, Immuneering Citizenship Report, Immuneering ESG Report, and Immuneering Environmental Report online.
Immuneering Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!